Region:Middle East
Author(s):Shubham
Product Code:KRAD6638
Pages:81
Published On:December 2025

By Type (Mode of Delivery):The market is segmented into various types of carotid artery stents, including self-expanding, balloon-expandable, drug-eluting, and bioabsorbable stents. At a global level, balloon-expandable stents account for a larger revenue share, while self-expanding carotid stents are increasingly preferred in complex and tortuous anatomies due to their flexibility and ability to better conform to the vessel wall. In Oman, self-expanding carotid stents are widely used in routine carotid stenting practice because of their ease of deployment and adaptability to the arterial anatomy, which makes them a preferred choice for many vascular surgeons and interventional cardiologists, especially in high?risk or anatomically challenging lesions. The increasing adoption of these stents is driven by clinical evidence supporting their effectiveness in maintaining luminal patency, reducing the risk of restenosis, and improving long-term neurological outcomes in appropriately selected patients.

By End-User:The end-user segmentation includes tertiary care hospitals, cardiac and vascular specialty centers, government & teaching hospitals, and private multispecialty hospitals and clinics. In line with broader carotid stent utilization patterns, tertiary care and large referral hospitals account for the majority of carotid artery stenting procedures because they host catheterization laboratories, hybrid operating rooms, and multidisciplinary stroke and vascular teams required for these complex interventions. The increasing number of high?risk patients being referred to these centers for carotid revascularization, coupled with the availability of advanced imaging, neuroprotection devices, and postoperative intensive care, is a significant factor contributing to their market leadership.

The Oman Carotid Artery Stents Market is characterized by a dynamic mix of regional and international players. Leading participants such as Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Terumo Corporation, B. Braun Melsungen AG, Johnson & Johnson (via Cordis legacy carotid portfolio), Cook Medical LLC, Cardinal Health, Inc., Stryker Corporation, W. L. Gore & Associates, Inc. (Gore Medical), Merit Medical Systems, Inc., Koninklijke Philips N.V. (Philips Healthcare), Siemens Healthineers AG, Edwards Lifesciences Corporation, Asahi Intecc Co., Ltd. contribute to innovation, geographic expansion, and service delivery in this space.
The Oman Carotid Artery Stents Market is poised for significant growth, driven by technological advancements and an increasing patient population. As healthcare infrastructure improves, more patients will gain access to innovative treatments. Additionally, the integration of digital health technologies will enhance patient monitoring and post-operative care. These trends indicate a shift towards more personalized and efficient healthcare solutions, which will likely shape the future landscape of carotid artery treatments in Oman.
| Segment | Sub-Segments |
|---|---|
| By Type (Mode of Delivery) | Self-expanding carotid stents Balloon-expandable carotid stents Drug-eluting carotid stents Bioabsorbable / biodegradable carotid stents |
| By End-User | Tertiary care hospitals Cardiac and vascular specialty centers Government & teaching hospitals Private multispecialty hospitals and clinics |
| By Material | Nitinol (nickel-titanium alloy) Cobalt-chromium alloys Stainless steel Polymer-based and hybrid materials |
| By Coating / Technology | Bare-metal carotid stents Drug-eluting / drug-coated carotid stents Bioabsorbable / bioresorbable scaffold stents Embolic protection–integrated systems |
| By Distribution Channel | Direct tenders to hospitals and health ministries Local distributors and agents Group purchasing organizations (GPOs) Others (regional wholesalers, importers) |
| By Region | Muscat Governorate Dhofar (including Salalah) Al Batinah (including Sohar) Other governorates (interior & northern regions) |
| By Patient Demographics / Risk Profile | Age group (45–64 years, 65+ years) Gender (Male, Female) Presence of comorbidities (Diabetes, Hypertension, Dyslipidemia, Smoking) Symptomatic vs. asymptomatic carotid artery disease |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Cardiovascular Surgeons | 90 | Interventional Cardiologists, Vascular Surgeons |
| Hospital Procurement Managers | 80 | Procurement Officers, Supply Chain Managers |
| Patients with Carotid Artery Stents | 70 | Post-operative Patients, Caregivers |
| Healthcare Policy Experts | 40 | Health Economists, Policy Analysts |
| Medical Device Distributors | 60 | Sales Managers, Product Specialists |
The Oman Carotid Artery Stents Market is valued at approximately USD 7 million, reflecting a historical analysis and comparison with global market trends. This valuation highlights the growing demand for carotid artery stenting solutions in the region.